BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27604489)

  • 1. Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.
    Mehra R; Vats P; Cieslik M; Cao X; Su F; Shukla S; Udager AM; Wang R; Pan J; Kasaian K; Lonigro R; Siddiqui J; Premkumar K; Palapattu G; Weizer A; Hafez KS; Wolf JS; Sangoi AR; Trpkov K; Osunkoya AO; Zhou M; Giannico G; McKenney JK; Dhanasekaran SM; Chinnaiyan AM
    Cancer Discov; 2016 Nov; 6(11):1258-1266. PubMed ID: 27604489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
    Wang L; Zhang Y; Chen YB; Skala SL; Al-Ahmadie HA; Wang X; Cao X; Veeneman BA; Chen J; Cieślik M; Qiao Y; Su F; Vats P; Siddiqui J; Xiao H; Sadimin ET; Epstein JI; Zhou M; Sangoi AR; Trpkov K; Osunkoya AO; Giannico GA; McKenney JK; Argani P; Tickoo SK; Reuter VE; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2018 Dec; 42(12):1571-1584. PubMed ID: 30285995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
    Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal mucinous tubular and spindle cell carcinoma: clinicopathological and whole exome sequencing analyses].
    Zou ZG; Wang YH; Zhou JX; Zhan SH; Zheng YS; Liu WS; Yuan X; Guo LC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):762-767. PubMed ID: 34405611
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.
    Ged Y; Chen YB; Knezevic A; Donoghue MTA; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Voss MH; Motzer RJ
    Clin Genitourin Cancer; 2019 Aug; 17(4):268-274.e1. PubMed ID: 31151928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
    Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
    J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma.
    Yang C; Cimera RS; Aryeequaye R; Jayakumaran G; Sarungbam J; Al-Ahmadie HA; Gopalan A; Sirintrapun SJ; Fine SW; Tickoo SK; Epstein JI; Reuter VE; Zhang Y; Chen YB
    Mod Pathol; 2021 Feb; 34(2):445-456. PubMed ID: 32879414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell changes in mucinous tubular and spindle cell carcinoma: cytoplasmic pallor/clearing within tubules, vacuoles or hybrid conventional clear cell carcinoma of kidney?
    Cao W; Huang B; Fei X; Huang X; Dai J; Zhou W; Xu Z; Su H; Cheng K; Sun F
    Int J Clin Exp Pathol; 2014; 7(7):4350-8. PubMed ID: 25120820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes.
    Kenney PA; Vikram R; Prasad SR; Tamboli P; Matin SF; Wood CG; Karam JA
    BJU Int; 2015 Jul; 116(1):85-92. PubMed ID: 25395040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney.
    Xu H; Li W; Zhu C; Cheng N; Li X; Hao F; Zhu J; Huang L; Wang R; Wang L; Luo Z; Wang F
    J Pathol; 2022 May; 257(1):53-67. PubMed ID: 35043389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: a histological, immunohistochemical, ultrastructural and FISH study.
    Kuroda N; Hes O; Michal M; Nemcova J; Gal V; Yamaguchi T; Kawada T; Imamura Y; Hayashi Y; Lee GH
    Histol Histopathol; 2008 Dec; 23(12):1517-23. PubMed ID: 18830937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathological study].
    Song HJ; Ma J; Zhou HB; Ma HH; Shi QL; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):444-8. PubMed ID: 22088369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.
    Ito K; Mikami S; Kuroda N; Nagashima Y; Tatsugami K; Masumori N; Kondo T; Takagi T; Nakanishi S; Eto M; Kamba T; Tomita Y; Matsuyama H; Tsushima T; Nakazawa H; Oya M; Kimura G; Shinohara N; Asano T
    Jpn J Clin Oncol; 2020 Oct; 50(11):1313-1320. PubMed ID: 33089867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal mucinous tubular and spindle cell carcinoma: report of four cases and literature review.
    Wang H; Xie J; Lu C; Zhang D; Jiang J
    Int J Clin Exp Pathol; 2015; 8(3):3122-6. PubMed ID: 26045827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway.
    Kai T; Tsukamoto Y; Hijiya N; Tokunaga A; Nakada C; Uchida T; Daa T; Iha H; Takahashi M; Nomura T; Sato F; Mimata H; Ikawa M; Seto M; Matsuura K; Moriyama M
    J Pathol; 2016 May; 239(1):97-108. PubMed ID: 26913567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers.
    Malouf GG; Flippot R; Dong Y; Dinatale RG; Chen YB; Su X; Compérat E; Rouprêt M; Mano R; Blum KA; Yao H; Mouawad R; Spano JP; Khayat D; Karam JA; Ho TH; Tickoo SK; Russo P; Hsieh JJ; Tannir NM; Hakimi AA
    Sci Rep; 2020 Jan; 10(1):701. PubMed ID: 31959902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-time Survival of a Renal Transplant Recipient With Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report.
    Kobari Y; Yoshida K; Minoda R; Fukuda H; Hata K; Unagami K; Iizuka J; Ishida H; Nagashima Y; Takagi T
    In Vivo; 2023; 37(3):1394-1398. PubMed ID: 37103106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathologic study of six cases.
    Hussain M; Ud Din N; Azam M; Loya A
    Indian J Pathol Microbiol; 2012; 55(4):439-42. PubMed ID: 23455776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous tubular and spindle cell carcinoma of the kidney with prominent papillary component, a non-classic morphologic variant. A histologic, immunohistochemical, electron microscopic and fluorescence in situ hybridization study.
    Alexiev BA; Burke AP; Drachenberg CB; Richards SM; Zou YS
    Pathol Res Pract; 2014 Jul; 210(7):454-8. PubMed ID: 24702883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.